BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 33737704)

  • 1. Venous thrombosis and predictors of relapse in eosinophil-related diseases.
    Réau V; Vallée A; Terrier B; Plessier A; Abisror N; Ackermann F; Benainous R; Bohelay G; Chabi-Charvillat ML; Cornec D; Desbois AC; Faguer S; Freymond N; Gaillet A; Hamidou M; Killian M; Le Jeune S; Marchetti A; Meyer G; Osorio-Perez F; Panel K; Rautou PE; Rohmer J; Simon N; Tcherakian C; Vasse M; Zuelgaray E; Lefevre G; Kahn JE; Groh M
    Sci Rep; 2021 Mar; 11(1):6388. PubMed ID: 33737704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilia in Rheumatologic/Vascular Disorders.
    Tamaki H; Chatterjee S; Langford CA
    Immunol Allergy Clin North Am; 2015 Aug; 35(3):453-76. PubMed ID: 26209895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Idiopathic Eosinophilic Vasculitis": Another Side of Hypereosinophilic Syndrome? A Comprehensive Analysis of 117 Cases in Asthma-Free Patients.
    Lefèvre G; Leurs A; Gibier JB; Copin MC; Staumont-Sallé D; Dezoteux F; Chenivesse C; Lopez B; Terriou L; Hachulla E; Launay D; Etienne N; Labalette M; DeGroote P; Pontana F; Quemeneur T; Hatron PY; Schleinitz N; Viallard JF; Hamidou M; Martin T; Morati-Hafsaoui C; Groh M; Lambert M; Kahn JE;
    J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1329-1340.e3. PubMed ID: 31863912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes of imatinib in patients with FIP1L1/ PDGFRA associated chronic eosinophilic leukemia: experience of a single center in China.
    Qu SQ; Qin TJ; Xu ZF; Zhang Y; Ai XF; Li B; Zhang HL; Fang LW; Pan LJ; Hu NB; Xiao ZJ
    Oncotarget; 2016 May; 7(22):33229-36. PubMed ID: 27120808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of commonly measured laboratory tests as biomarkers of disease activity and predictors of relapse in eosinophilic granulomatosis with polyangiitis.
    Grayson PC; Monach PA; Pagnoux C; Cuthbertson D; Carette S; Hoffman GS; Khalidi NA; Koening CL; Langford CA; Maksimowicz-McKinnon K; Seo P; Specks U; Ytterberg SR; Merkel PA;
    Rheumatology (Oxford); 2015 Aug; 54(8):1351-9. PubMed ID: 25406357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The severity of FIP1L1-PDGFRA-positive chronic eosinophilic leukaemia is associated with polymorphic variation at the IL5RA locus.
    Burgstaller S; Kreil S; Waghorn K; Metzgeroth G; Preudhomme C; Zoi K; White H; Cilloni D; Zoi C; Brito-Babapulle F; Walz C; Reiter A; Cross NC
    Leukemia; 2007 Dec; 21(12):2428-32. PubMed ID: 17914408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pediatric idiopathic hypereosinophilic syndrome with pulmonary embolism: a case report and review of literature].
    Dong N; Dong XY
    Zhonghua Er Ke Za Zhi; 2017 Oct; 55(10):775-779. PubMed ID: 29050117
    [No Abstract]   [Full Text] [Related]  

  • 8. [Eosinophilia, Churg-Strauss syndrome and hypereosinophilic syndrome].
    Cogan E; Roufosse F
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S256-8. PubMed ID: 17961861
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical features of hypereosinophilic syndrome: FIP1L1-PDGFRA fusion gene-positive disease is a distinct clinical entity with myeloproliferative features and a poor response to corticosteroid.
    Miyazawa K; Kakazu N; Ohyashiki K
    Int J Hematol; 2007 Jan; 85(1):5-10. PubMed ID: 17261495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.
    Pardanani A; Brockman SR; Paternoster SF; Flynn HC; Ketterling RP; Lasho TL; Ho CL; Li CY; Dewald GW; Tefferi A
    Blood; 2004 Nov; 104(10):3038-45. PubMed ID: 15284118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies.
    Odinius TO; Buschhorn L; Wagner C; Hauch RT; Dill V; Dechant M; Buck MC; Shoumariyeh K; Moog P; Schwaab J; Reiter A; Brockow K; Götze K; Bassermann F; Höckendorf U; Branca C; Jost PJ; Jilg S
    J Cancer Res Clin Oncol; 2022 Feb; 148(2):331-340. PubMed ID: 34654952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilia: a pragmatic approach to diagnosis and treatment.
    Klion AD
    Hematology Am Soc Hematol Educ Program; 2015; 2015():92-7. PubMed ID: 26637706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1-PDGFRA fusion transcript--results of Polish multicentre study.
    Helbig G; Moskwa A; Hus M; Piszcz J; Swiderska A; Urbanowicz A; Całbecka M; Gajkowska J; Seferyńska I; Hałasz M; Woszczyk D; Markiewicz M; Krzemień S
    Hematol Oncol; 2010 Jun; 28(2):93-7. PubMed ID: 19728396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid neoplasms with eosinophilia.
    Reiter A; Gotlib J
    Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence and causes of hypereosinophilia (corrected) in the patients of a university hospital].
    Kim DW; Shin MG; Yun HK; Kim SH; Shin JH; Suh SP; Ryang DW
    Korean J Lab Med; 2009 Jun; 29(3):185-93. PubMed ID: 19571614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern diagnosis and treatment of primary eosinophilia.
    Tefferi A
    Acta Haematol; 2005; 114(1):52-60. PubMed ID: 15995325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing.
    Klion AD; Robyn J; Maric I; Fu W; Schmid L; Lemery S; Noel P; Law MA; Hartsell M; Talar-Williams C; Fay MP; Dunbar CE; Nutman TB
    Blood; 2007 Nov; 110(10):3552-6. PubMed ID: 17709602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin denervation and cutaneous vasculitis in eosinophilia-associated neuropathy.
    Chao CC; Hsieh ST; Shun CT; Hsieh SC
    Arch Neurol; 2007 Jul; 64(7):959-65. PubMed ID: 17620485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FIP1L1-PDGFRA positive chronic eosinophilic leukemia in Tunisian patients.
    Menif S; Omri H; Hafsia R; Ben Romdhane N; Turki S; Meddeb B; Dellagi K
    Pathol Biol (Paris); 2007 Jun; 55(5):242-5. PubMed ID: 17137731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
    Cottin V; Bel E; Bottero P; Dalhoff K; Humbert M; Lazor R; Sinico RA; Sivasothy P; Wechsler ME; Groh M; Marchand-Adam S; Khouatra C; Wallaert B; Taillé C; Delaval P; Cadranel J; Bonniaud P; Prévot G; Hirschi S; Gondouin A; Dunogué B; Chatté G; Briault C; Pagnoux C; Jayne D; Guillevin L; Cordier JF;
    Autoimmun Rev; 2017 Jan; 16(1):1-9. PubMed ID: 27671089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.